Baseline patient and disease characteristics by treatment group
| . | Propranolol . | Control . |
|---|---|---|
| Age, mean (range), y | 59 (36-72) | 63 (54-74) |
| Sex, % | ||
| Male | 58 | 62 |
| Female | 42 | 38 |
| Race | ||
| White, % | 67 | 85 |
| Black or African American, % | 33 | 15 |
| BMI, mean (range) | 30 (25.9-33.6) | 33 (30.1-35.9) |
| KPS | 88 | 90 |
| ≥90 | 7 | 11 |
| <90 | 5 | 2 |
| IMWG risk score, % | ||
| High-risk disease | 25 | 46 |
| Standard-risk disease | 75 | 54 |
| T staging | ||
| Stage 1 | 3 | 5 |
| Stage 2 | 7 | 5 |
| Stage 3 | 1 | 2 |
| Smoking history, % | 33 | 54 |
| Income status, $ | ||
| <23 000 | 1 | 2 |
| 23 000-34 999 | 4 | 1 |
| 35 000-44 999 | 1 | 1 |
| 45 000-54 999 | 2 | 2 |
| 55 000-64 999 | 0 | 1 |
| >75 000 | 4 | 3 |
| Prefer not to answer | 0 | 3 |
| Education | ||
| 8th grade education or less | 0 | 1 |
| Some high school, no diploma | 0 | 2 |
| High school diploma, GED, or equivalent | 5 | 2 |
| Postsecondary work (vocational, technical, some college) | 5 | 5 |
| 4-y degree | 0 | 1 |
| Master’s degree | 1 | 1 |
| Postgraduate/professional degree (eg, PhD, MD, JD) | 0 | 1 |
| Prefer not to answer | 1 | 0 |
| Outpatient transplant, % | 25 | 23 |
| CD34+ dose, 106/kg | 5.1 | 4.6 |
| Clinical response pretransplant | ||
| Stable disease | 1 | 0 |
| Partial response | 5 | 5 |
| Very good partial response | 5 | 5 |
| Complete response | 1 | 3 |
| . | Propranolol . | Control . |
|---|---|---|
| Age, mean (range), y | 59 (36-72) | 63 (54-74) |
| Sex, % | ||
| Male | 58 | 62 |
| Female | 42 | 38 |
| Race | ||
| White, % | 67 | 85 |
| Black or African American, % | 33 | 15 |
| BMI, mean (range) | 30 (25.9-33.6) | 33 (30.1-35.9) |
| KPS | 88 | 90 |
| ≥90 | 7 | 11 |
| <90 | 5 | 2 |
| IMWG risk score, % | ||
| High-risk disease | 25 | 46 |
| Standard-risk disease | 75 | 54 |
| T staging | ||
| Stage 1 | 3 | 5 |
| Stage 2 | 7 | 5 |
| Stage 3 | 1 | 2 |
| Smoking history, % | 33 | 54 |
| Income status, $ | ||
| <23 000 | 1 | 2 |
| 23 000-34 999 | 4 | 1 |
| 35 000-44 999 | 1 | 1 |
| 45 000-54 999 | 2 | 2 |
| 55 000-64 999 | 0 | 1 |
| >75 000 | 4 | 3 |
| Prefer not to answer | 0 | 3 |
| Education | ||
| 8th grade education or less | 0 | 1 |
| Some high school, no diploma | 0 | 2 |
| High school diploma, GED, or equivalent | 5 | 2 |
| Postsecondary work (vocational, technical, some college) | 5 | 5 |
| 4-y degree | 0 | 1 |
| Master’s degree | 1 | 1 |
| Postgraduate/professional degree (eg, PhD, MD, JD) | 0 | 1 |
| Prefer not to answer | 1 | 0 |
| Outpatient transplant, % | 25 | 23 |
| CD34+ dose, 106/kg | 5.1 | 4.6 |
| Clinical response pretransplant | ||
| Stable disease | 1 | 0 |
| Partial response | 5 | 5 |
| Very good partial response | 5 | 5 |
| Complete response | 1 | 3 |
Values are number of patients, unless otherwise indicated.
IMWG, International Myeloma Working Group.